![](../../files/images/goods/63612-50-0.png)
Nilutamide
CAS No. 63612-50-0
Nilutamide ( RU-23908 )
Catalog No. M15410 CAS No. 63612-50-0
Nilutamide is an antineoplastic hormonal agent primarily used in the treatment of prostate Y. Nilutamide is a pure, nonsteroidal anti-androgen with affinity for androgen receptors (but not for progestogen, estrogen, or glucocorticoid receptors).
Purity : >98%(HPLC)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
Size | Price / USD | Stock | Quantity |
100MG | 35 | In Stock |
![]() ![]() |
200MG | 50 | In Stock |
![]() ![]() |
500MG | 82 | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameNilutamide
-
NoteResearch use only, not for human use.
-
Brief DescriptionNilutamide is an antineoplastic hormonal agent primarily used in the treatment of prostate Y. Nilutamide is a pure, nonsteroidal anti-androgen with affinity for androgen receptors (but not for progestogen, estrogen, or glucocorticoid receptors).
-
DescriptionNilutamide is an antineoplastic hormonal agent primarily used in the treatment of prostate Y. Nilutamide is a pure, nonsteroidal anti-androgen with affinity for androgen receptors (but not for progestogen, estrogen, or glucocorticoid receptors). Consequently, Nilutamide blocks the action of androgens of adrenal and testicular origin that stimulate the growth of normal and malignant prostatic tissue. Prostate Y is mostly androgen-dependent and can be treated with surgical or chemical castration. To date, antiandrogen monotherapy has not consistently been shown to be equivalent to castration.
-
SynonymsRU-23908
-
PathwayEndocrinology/Hormones
-
TargetAndrogen Receptor (AR)
-
RecptorAndrogen Receptor
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number63612-50-0
-
Formula Weight317.22
-
Molecular FormulaC12H10F3N3O4
-
Purity>98%(HPLC)
-
SolubilityDMSO: 10 mM
-
SMILESO=C1N(C2=CC=C([N+]([O-])=O)C(C(F)(F)F)=C2)C(C(C)(C)N1)=O
-
Chemical Name5,5-dimethyl-3-(4-nitro-3-(trifluoromethyl)phenyl)imidazolidine-2,4-dione
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Raynaud JP. Am J Clin Oncol. 1988;11 Suppl 2:S132-47.
molnova catalog
![](/themes/theme/en/images/ct.png)
![](/themes/theme/en/images/ct2.png)
related products
-
AZD3514
AZD3514 is a potent and oral androgen receptor downregulator with Ki of 2.2 μM and has ability of reducing AR protein expression.Phase 1.
-
Proxalutamide
A potent androgen receptor (AR) antagonist with ability to down regulate AR protein level in prostate cancer cells.
-
EPI-001
EPI-001 is a small molecule that blocks transactivation of the androgen Receptor (AR) NTD (IC50=6 uM).